摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[1,1'-联苯基]-3,4'-二醇 | 18855-13-5

中文名称
[1,1'-联苯基]-3,4'-二醇
中文别名
——
英文名称
Biphenyl-3,4'-diol
英文别名
3,4'-dihydroxybiphenyl;1,1'-biphenyl-3,4'-diol;3,4'-biphenyldiol;(1,1'-biphenyl)-3,4'-diol;[1,1'-Biphenyl]-3,4'-diol;3-(4-hydroxyphenyl)phenol
[1,1'-联苯基]-3,4'-二醇化学式
CAS
18855-13-5
化学式
C12H10O2
mdl
——
分子量
186.21
InChiKey
BWBGEYQWIHXDKY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    190 °C
  • 沸点:
    384.2±25.0 °C(Predicted)
  • 密度:
    1.228±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2907299090

SDS

SDS:4073292e83157d024b1a332d3980cf3c
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-(3-Hydroxyphenyl)phenol
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-(3-Hydroxyphenyl)phenol
CAS number: 18855-13-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H10O2
Molecular weight: 186.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    通过纯活性香蕉形液晶的原位光聚合获得的 SmCP 网络化薄膜
    摘要:
    已经进行了反应性香蕉形化合物的合成和表征,并评估了它们在 SmCP 中间相中光聚合的能力。X 射线研究证实了这些化合物中存在 SmCP 液晶相。这些分子的聚合已通过量热技术以及室温下机械稳定的 SmCP 有序游离薄膜的制备和表征得到证实。此外,聚合薄膜在没有电场的情况下在室温下表现出二次谐波产生活性。
    DOI:
    10.1021/ja048437k
  • 作为产物:
    参考文献:
    名称:
    METHOD OF PRODUCING BIPHENOLIC COMPOUND, NOVEL BIPHENYL COMPOUND AND SYNTHESIS METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR TREATING PARKINSON'S DISEASE
    摘要:
    本发明公开了一种生产厚朴酚及其类似物的方法,以及由此制备的新颖中间体。还公开了一种用于治疗帕金森病的药物组合物,该组合物包含厚朴酚和/或其类似物。
    公开号:
    US20130303788A1
  • 作为试剂:
    描述:
    2-(3'-methoxy-biphenyl-4-yloxy)-tetrahydro-pyran对甲苯磺酸三溴化硼[1,1'-联苯基]-3,4'-二醇 作用下, 以Therefore, biphenyl-3,4′-diol (compound 32) as a solid was obtained (90% yield over two steps)的产率得到[1,1'-联苯基]-3,4'-二醇
    参考文献:
    名称:
    METHOD OF PRODUCING BIPHENOLIC COMPOUND, NOVEL BIPHENYL COMPOUND AND SYNTHESIS METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR TREATING PARKINSON'S DISEASE
    摘要:
    本文介绍了一种生产本草酚和其类似物的方法,以及由此制备的新型中间体。本文还公开了一种治疗帕金森病的药物组合物,其中包含本草酚和/或其类似物。
    公开号:
    US20130303788A1
点击查看最新优质反应信息

文献信息

  • Antibacterial macrocycles with substituted biphenyl
    申请人:Endermann Rainer
    公开号:US20070099885A1
    公开(公告)日:2007-05-03
    The invention relates to antibacterial macrocycles with substituted biphenyl and processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially of bacterial infections.
    这项发明涉及具有取代联苯基的抗菌大环化合物,以及它们的制备方法,它们用于治疗和/或预防疾病,以及它们用于生产用于治疗和/或预防疾病的药物,特别是细菌感染。
  • Aromatic Amide Compound
    申请人:Nair Kamlesh P.
    公开号:US20130048911A1
    公开(公告)日:2013-02-28
    An aromatic amide compound having the following general formula (I) is provided: wherein, X 1 and X 2 are independently C(O)HN or NHC(O); G 1 , G 2 and G 3 are independently hydrogen, C(O)HN-phenyl, or NHC(O)-phenyl, wherein at least one of G 1 , G 2 and G 3 is C(O)HN-phenyl or NHC(O)-phenyl; Q 1 , Q 2 , and Q 3 are independently hydrogen, C(O)HN-phenyl, or NHC(O)-phenyl, wherein at least one of Q 1 , Q 2 , and Q 3 is C(O)HN-phenyl or NHC(O)-phenyl; R 5 is halo, haloalkyl, alkyl, alkenyl, aryl, heteroaryl, cycloalkyl, or heterocyclyl; and m is from 0 to 4.
    提供了一种具有以下通式(I)的芳香酰胺化合物:其中,X1和X2独立地为C(O)HN或NHC(O);G1、G2和G3独立地为氢、C(O)HN-苯基或NHC(O)-苯基,其中至少一个G1、G2和G3为C(O)HN-苯基或NHC(O)-苯基;Q1、Q2和Q3独立地为氢、C(O)HN-苯基或NHC(O)-苯基,其中至少一个Q1、Q2和Q3为C(O)HN-苯基或NHC(O)-苯基;R5为卤素、卤代烷基、烷基、烯基、芳基、杂芳基、环烷基或杂环烷基;m为0至4。
  • Polymerizable compound and liquid crystal composition including it
    申请人:Ito Maiko
    公开号:US08394468B2
    公开(公告)日:2013-03-12
    Provided is a polymerizable compound with large solubility in a liquid crystal composition and high reactivity irradiated by ultraviolet in the longer wavelength range. Provided is a liquid crystal composition that satisfies at least one of characteristics such as high maximum temperature of a nematic phase, low minimum temperature of a nematic phase, small viscosity, suitable optical anisotropy, large negative dielectric anisotropy, large specific resistance, high stability to ultraviolet light and high stability to heat, or that is suitably balanced between at least two of the characteristics. Provided is the polymerizable compound wherein at least one of a 1,3-phenylene structure and a 2,7-fluorenediyl structure is introduced to the polymerizable compound to give stable displays by forming a polymer with a high degree of polymerization in a PSA device production process using longer wavelengths, the liquid crystal composition includes the compound, and the liquid crystal display device contains the composition.
    提供了一种具有较大溶解度的聚合物化合物,其在液晶组合物中具有高反应性,可被紫外线在较长波长范围内辐照。提供了一种液晶组合物,满足至少以下特征之一:向列相的最高温度高,向列相的最低温度低,粘度小,适当的光学各向异性,较大的负介电各向异性,较大的特定电阻,对紫外光的高稳定性和对热的高稳定性,或在至少两种特征之间适当平衡。提供了一种聚合物化合物,其中至少引入了1,3-苯基结构和2,7-二基结构之一到聚合物化合物中,通过在使用较长波长的PSA设备生产过程中形成具有高聚合度的聚合物,从而提供稳定的显示,液晶组合物包括该化合物,液晶显示装置包含该组合物。
  • Small Molecule NF-κB Inhibitors as Immune Potentiators for Enhancement of Vaccine Adjuvants
    作者:Brittany A. Moser、Yoseline Escalante-Buendia、Rachel C. Steinhardt、Matthew G. Rosenberger、Britteny J. Cassaidy、Nihesh Naorem、Alfred C. Chon、Minh H. Nguyen、Ngoctran T. Tran、Aaron P. Esser-Kahn
    DOI:10.3389/fimmu.2020.511513
    日期:——
    Adjuvants are added to vaccines to enhance the immune response and provide increased protection against disease. In the last decade, hundreds of synthetic immune adjuvants have been created, but many induce undesirable levels of proinflammatory cytokines including TNF-α and IL-6. Here we present small molecule NF-κB inhibitors that can be used in combination with an immune adjuvant to both decrease
    疫苗中添加佐剂可增强免疫反应并增强对疾病的保护。在过去的十年中,数百种合成免疫佐剂被创造出来,但许多都会诱导促炎细胞因子(包括 TNF-α 和 IL-6)达到不良平。在这里,我们提出了小分子 NF-κB 抑制剂,可与免疫佐剂联合使用,以减少与耐受性差相关的标记物并改善疫苗接种的保护反应。此外,我们合成了和厚朴酚衍生物库,确定了几种有希望用于疫苗制剂的候选物。
  • Aerobic Oxidative Heck/Dehydrogenation Reactions of Cyclohexenones: Efficient Access to<i>meta</i>-Substituted Phenols
    作者:Yusuke Izawa、Changwu Zheng、Shannon S. Stahl
    DOI:10.1002/anie.201209457
    日期:2013.3.25
    catalyst, employing a 6,6′‐dimethyl‐2,2′‐bipyridine ligand, promotes both the aerobic oxidative Heck coupling and dehydrogenation reactions of cyclohexenones. These reactions may be combined in a one‐pot sequence to enable the straightforward synthesis of meta‐substituted phenols (see scheme).
    争夺(间)位:一种新型双阳离子(II)催化剂,采用 6,6'-二甲基-2,2'-联吡啶配体,促进环己烯酮的有氧氧化 Heck 偶联和脱氢反应。这些反应可以以一锅法顺序组合,以实现间位取代的直接合成(参见方案)。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫